Cited by 491Myeloproliferative Neoplasms: Diagnosis and TreatmentNeutrophil, Myeloperoxidase and Oxidative MechanismsPlatelet Disorders and Treatments

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

Open access

Abstract

Thrombosis in myeloproliferative neoplasms is associated with increased NETosis that can be targeted with JAK inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aan8292

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • JAK2 mutations prime neutrophils to form neutrophil extracellular traps, leading to thrombosis, which may also contribute to poor cardiovascular outcomes.

    “Furthermore, JAK2 mutations prime neutrophils to form neutrophil extracellular traps, leading to thrombosis, which may also contribute to poor cardiovascular outcomes 82.”

    From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [82]

  • Individuals with CHIP-associated JAK2 mutations were reported to have an approximately 12 times greater risk of developing venous thrombosis than those without CHIP, whereas individuals with mutations in other CHIP-associated genes had a doubling of the risk.

    “In a separate study (83), individuals with CHIP-associated JAK2 mutations were reported to have a ~12 times greater risk of developing venous thrombosis than those without CHIP, whereas individuals with mutations in other CHIP-associated genes had a doubling of the risk 82.”

    From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [82]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Wolach, O., Sellar, R. S., Martinod, K., Cherpokova, D., McConkey, M., Chappell, R. J., Silver, A. J., Adams, D., Castellano, C. A., Schneider, R. K., Padera, R. F., DeAngelo, D. J., Wadleigh, M., Steensma, D. P., Galinsky, I., Stone, R. M., Genovese, G., McCarroll, S. A., Iliadou, B., Hultman, C., Neuberg, D., Mullally, A., Wagner, D. D., & Ebert, B. L.
Affiliations
  • Brigham and Women's Hospital (US)
  • Broad Institute (US)
  • Boston Children's Hospital (US)
  • Dana-Farber Cancer Institute (US)
  • Karolinska Institutet (SE)
Corresponding author
  • Wolach, Ofir
  • Sellar, Rob S.
  • Ebert, Benjamin L.
Venue
Science Translational Medicine
Published
2018-04-11
Volume
10
Issue
436
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2796704538
Cited by
481
References
41
Citations by year
2026: 50 · 2025: 58 · 2024: 66 · 2023: 58 · 2022: 73 · 2021: 69 · 2020: 48 · 2019: 44 · 2018: 13
FWCI
24.67
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Funders
  • National Institutes of Health (R01HL082945)
  • Howard Hughes Medical Institute
  • Leukemia and Lymphoma Society
Topics
  • Health Sciences › Medicine › Hematology › Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords
neutrophil extracellular traps, thrombosis, myeloproliferative neoplasms, JAK2 inhibition, neutrophil function, NETosis
MeSH terms
Protein-Arginine Deiminase Type 4, Animals, Female, Hydrolases, Myeloproliferative Disorders, Nitriles, Pyrazoles, Pyrimidines, Thrombosis, Signal Transduction, Case-Control Studies, Hematologic Neoplasms, Cell Proliferation, STAT Transcription Factors, Mice, Janus Kinases, Janus Kinase 2, Extracellular Traps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review